Effects of resveratrol and nebivolol on isolated vascular and cardiac tissues from young rats

Advances in Pharmacological Sciences

Volumn 2014, Issue , 2014, Pages

  Pullen, Candice ^a   Coulson, Fiona R ^a   Fenning, Andrew ^a  

^a CENTRAL QUEENSLAND UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; ACETYLCHOLINE; N(G) NITROARGININE METHYL ESTER; NEBIVOLOL; NORADRENALIN; POTASSIUM CHLORIDE; RESVERATROL; VERAPAMIL;

ADIPOSE TISSUE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONNECTIVE TISSUE; CONTROLLED STUDY; HEART; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART PAPILLARY MUSCLE; HEART REPOLARIZATION; IN VITRO STUDY; MALE; MESENTERIC ARTERY; MESENTERY BLOOD VESSEL; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASCULAR TISSUE; VASODILATATION; YOUNG ADULT;

EID: 84896141434     PISSN: 16876334     EISSN: 16876342     Source Type: Journal    
DOI: 10.1155/2014/720386     Document Type: Article

References (36)

1. National Heart Foundation, Data and Statistics 2012
2. Bhatt S. R., Lokhandwala M. F., Banday A. A., Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. European Journal of Pharmacology 2011 667 1-3 258 264 2-s2.0-80052037390 10.1016/j.ejphar.2011.05. 026
3. Mudau M., Genis A., Lochner A., Strijdom H., Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovascular Journal of Africa 2012 23 222 231 10.5830/CVJA-2011-068
4. Chlopicki S., Kozlovski V. I., Gryglewski R. J., No-dependent vasodilation induced by nebivolol in coronary circulation is not mediated by β -adrenoceptors or by 5 HT1A-receptors. Journal of Physiology and Pharmacology 2002 53 4 615 624 2-s2.0-0036908156 (Pubitemid 36014806)
5. Turan B., Tuncay E., Vassort G., Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies. Journal of Bioenergetics and Biomembranes 2012 44 281 296 2-s2.0-84858610455 10.1007/s10863-012-9429-0
6. Cockcroft J. R., Chowienczyk P. J., Brett S. E., Chen C. P.-H., Dupont A. G., Van Nueten L., Wooding S. J., Ritter J. M., Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism. Journal of Pharmacology and Experimental Therapeutics 1995 274 3 1067 1071 2-s2.0-0029129670
7. Sacco G., Evangelista S., Manzini S., Parlani M., Bigioni M., Combined antihypertensive and cardioprotective effects of nebivolol and hydrochlorothiazide in spontaneous hypertensive rats. Future Cardiology 2011 7 6 757 763 2-s2.0-80555127382 10.2217/fca.11.70
8. Thandapilly S. J., Wojciechowski P., Behbahani J., Louis X. L., Yu L., Juric D., Kopilas M. A., Anderson H. D., Netticadan T., Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. American Journal of Hypertension 2010 23 2 192 196 2-s2.0-75549083493 10.1038/ajh.2009.228
9. Merchant N., Rahman S. T., Ferdinand K. C., Haque T., Umpierrez G. E., Khan B. V., Effects of nebivolol in obese African Americans with hypertension (NOAAH): markers of inflammation and obesity in response to exercise-induced stress. Journal of Human Hypertension 2011 25 3 196 202 2-s2.0-79951680124 10.1038/jhh.2010.39
10. Wang S. J., Bo Q. Y., Zhao X. H., Yang X., Chi Z. F., Liu X. W., Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mtor signaling. Brain Research 2013 1492 122 129 10.1016/j.brainres.2012.11.027
11. Zhou X., Ma L., Habibi J., Whaley-Connell A., Hayden M. R., Tilmon R. D., Brown A. N., Kim J.-A., Demarco V. G., Sowers J. R., Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the zucker obese rat. Hypertension 2010 55 4 880 888 2-s2.0-77950466818 10.1161/HYPERTENSIONAHA.109.145136
12. Chang C.-C., Chang C.-Y., Wu Y.-T., Huang J.-P., Yen T.-H., Hung L.-M., Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase. Journal of Biomedical Science 2011 18 1, article 47 2-s2.0-79959442302 10.1186/1423-0127-18-47
13. Li H.-F., Tian Z.-F., Qiu X.-Q., Wu J.-X., Zhang P., Jia Z.-J., A study of mechanisms involved in vasodilatation induced by resveratrol in isolated porcine coronary artery. Physiological Research 2006 55 4 365 372 2-s2.0-33747886782 (Pubitemid 44291093)
14. Nagaoka T., Hein T. W., Yoshida A., Kuo L., Resveratrol, a component of red wine, elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels. Investigative Ophthalmology and Visual Science 2007 48 9 4232 4239 2-s2.0-35148851909 10.1167/iovs.07-0094 (Pubitemid 351261054)
15. Manna S. K., Mukhopadhyay A., Aggarwal B. B., Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF- B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. Journal of Immunology 2000 164 12 6509 6519 2-s2.0-0034660659 (Pubitemid 30408836)
16. Chen W.-P., Su M.-J., Hung L.-M., In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant. European Journal of Pharmacology 2007 554 2-3 196 204 2-s2.0-33845436010 10.1016/j.ejphar.2006.10.016 (Pubitemid 44895325)
17. Rimbaud S., Ruiz M., Piquereau J., Mateo P., Fortin D., Veksler V., Garnier A., Ventura-Clapier R., Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure. PLoS ONE 2011 6 10 2-s2.0-80054736902 10.1371/journal.pone.0026391 e26391
18. Chan V., Fenning A., Iyer A., Hoey A., Brown L., Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats. Current Pharmaceutical Biotechnology 2011 12 3 429 436 2-s2.0-79551655242 10.2174/138920111794480552
19. Lekakis J., Rallidis L. S., Andreadou I., Vamvakou G., Kazantzoglou G., Magiatis P., Skaltsounis A.-L., Kremastinos D. T., Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. European Journal of Cardiovascular Prevention and Rehabilitation 2005 12 6 596 600 2-s2.0-33644878762 10.1097/00149831-200512000-00013 (Pubitemid 44972990)
20. Wong R. H. X., Howe P. R. C., Buckley J. D., Coates A. M., Kunz I., Berry N. M., Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutrition, Metabolism and Cardiovascular Diseases 2011 21 11 851 856 2-s2.0-80054005789 10.1016/j.numecd.2010.03.003
21. Gojkovic-Bukarica L., Novakovic A., Kanjuh V., Bumbasirevic M., Lesic A., Heinle H., A role of ion channels in the endothelium-independent relaxation of rat mesenteric artery induced by resveratrol. Journal of Pharmacological Sciences 2008 108 1 124 130 2-s2.0-52949145570 10.1254/jphs.08128FP
22. Broeders M. A. W., Doevendans P. A., Bekkers B. C. A. M., Bronsaer R., Van Gorsel E., Heemskerk J. W. M., Egbrink M. G. A. O., Van Breda E., Reneman R. S., Van Der Zee R., Nebivolol: a third-generation β -blocker that augments vascular nitric oxide release. Endothelial β 2-adrenergic receptor-mediated nitric oxide production. Circulation 2000 102 6 677 684 2-s2.0-0034622538 (Pubitemid 30640669)
23. Ignarro L. J., Different pharmacological properties of two enantiomers in a unique β -blocker, nebivolol. Cardiovascular Therapeutics 2008 26 2 115 134 2-s2.0-46849117086 10.1111/j.1527-3466.2008.00044.x (Pubitemid 351952828)
24. Tran Quang T., Rozec B., Audigane L., Gauthier C., Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta. British Journal of Pharmacology 2009 156 4 601 608 2-s2.0-65349146446 10.1111/j.1476-5381.2009.00074.x
25. Galetta F., Franzoni F., Magagna A., Femia F. R., Pentimone F., Santoro G., Carpi A., Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy. Biomedicine and Pharmacotherapy 2005 59 1-2 15 19 2-s2.0-14644401064 10.1016/j.biopha.2004.05.016 (Pubitemid 40312274)
26. Lu H. R., Remeysen P., De Clerck F., Antiarrhythmic effects of nebivolol in experimental models in vivo. Journal of Cardiovascular Pharmacology 1994 24 6 986 993 2-s2.0-0028609767
27. Fenning A., Harrison G., Rose'meyer R., Hoey A., Brown L., L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats. The American Journal of Physiology-Heart and Circulatory Physiology 2005 289 4 H1408 H1416 2-s2.0-25444450268 10.1152/ajpheart.00140.2005 (Pubitemid 41368981)
28. Mulvany M. J., Procedures For Investigation of Small Vessels Using Small Vessel Myograph 2004 Danish Myo Technology
29. Liew R., Stagg M. A., MacLeod K. T., Collins P., The red wine polyphenol, resveratrol, exerts acute direct actions on guinea-pig ventricular myocytes. European Journal of Pharmacology 2005 519 1-2 1 8 2-s2.0-27744456142 10.1016/j.ejphar.2005.06.017 (Pubitemid 43181157)
30. Zhao J., Ma H.-J., Dong J.-H., Zhang L.-P., Liu H.-L., Wang Q.-S., Electrophysiological effects of resveratrol on guinea pig papillary muscles. Acta Physiologica Sinica 2004 56 6 708 712 2-s2.0-29744447332
31. Zhang L.-P., Yin J.-X., Liu Z., Zhang Y., Wang Q.-S., Zhao J., Effect of resveratrol on L-type calcium current in rat ventricular myocytes. Acta Pharmacologica Sinica 2006 27 2 179 183 2-s2.0-31644440869 10.1111/j.1745-7254. 2006.00250.x (Pubitemid 43171156)
32. Arlock P., Wohlfart B., Sjöberg T., Steen S., The negative inotropic effect of esmolol on isolated cardiac muscle. Scandinavian Cardiovascular Journal 2005 39 4 250 254 2-s2.0-25444476096 10.1080/14017430510035952 (Pubitemid 41358594)
33. Novakovic A., Bukarica L. G., Kanjuh V., Heinle H., Potassium channels-mediated vasorelaxation of rat aorta induced by resveratrol. Basic and Clinical Pharmacology and Toxicology 2006 99 5 360 364 2-s2.0-33750565407 10.1111/j.1742-7843.2006.pto-531.x (Pubitemid 44673316)
34. Lekakis J. P., Protogerou A., Papamichael C., Vamvakou G., Iconomidis I., Fici F., Mavrikakis M., Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease. Cardiovascular Drugs and Therapy 2005 19 4 277 281 2-s2.0-28844434160 10.1007/s10557-005-3117-9 (Pubitemid 41778808)
35. Yesmine S., Connolly K., Hill N., Coulson F. R., Fenning A. S., Electrophysiological, vasoactive, and gastromodulatory effects of stevia in healthy wistar rats. Planta Medica 2013 79 11 909 915
36. Hao H. D., He L. R., Mechanisms of cardiovascular protection by resveratrol. Journal of Medicinal Food 2004 7 3 290 298 2-s2.0-4644309893 10.1089/jmf.2004.7.290 (Pubitemid 39299486)